A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
What the trial team says
This is an open-label, multicenter Phase 2 study evaluating BMS-986504 in participants with advanced and/or metastatic solid tumors that have MTAP deletion. The study includes a monotherapy component and a combination component in which BMS-986504 is given with other anti-cancer agents. The trial will assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of BMS-986504 alone and in combination regimens.
Key facts
- Registry number
- NCT07492680
- Stage of testing
- Phase 2
- Conditions studied
- Solid Tumors
Where it is running
This trial lists 58 sites.
-
Barcelona [Barcelona]
- Local Institution - 0068 (Barcelona)
- Local Institution - 0071 (Hospitalet)
-
Beijing Municipality
- Local Institution - 0155 (Beijing)
-
British Columbia
- Local Institution - 0051 (Vancouver)
-
Bruxelles-Capitale, Région de
- UZ Brussel (Brussels)
- Cliniques universitaires Saint-Luc (Brussels)
-
California
- Local Institution - 0096 (San Francisco)
-
Chongqing Municipality
- Local Institution - 0185 (Chongqing)
-
Colorado
- Local Institution - 0182 (Aurora)
-
Côte-d'Or
- Local Institution - 0078 (Dijon)
-
France
- Hôpital Saint-Louis (Paris)
-
Georgia
- Emory University - Winship Cancer Institute (Atlanta)
-
Germany
- Universitaetsklinikum Hamburg (Hamburg)
- Local Institution - 0039 (Heidelberg)
- Universitaetsklinikum Leipzig (Leipzig)
- Klinikum Rechts der Isar der Technischen Universitaet Muenchen (München)
- Local Institution - 0047 (Würzburg)
-
Guangdong
- Local Institution - 0184 (Guangzhou)
-
Henan
- The First Affiliated Hospital of Henan Medical University (Xinxiang)
-
Hong Kong
- Local Institution - 0150 (Hksar)
- Local Institution - 0063 (Shatin)
-
Hordaland
- Haukeland Universitetssjukehus (Bergen)
-
Ireland
- Cork University Hospital (Cork)
- Mater Misericordiae University Hospital (MMUH) (Dublin)
- Local Institution - 0146 (Dublin)
-
Italy
- Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII (Bergamo)
- Fondazione IRCCS Istituto Nazionale dei Tumori (Milan)
- Istituto Nazionale Tumori IRCCS Fondazione Pascale (Naples)
- Hospital Santa Maria della Misericordia in Perugia (Perugia)
-
Madrid, Comunidad de
- Hospital General Universitario Gregorio Marañon (Madrid)
-
Maryland
- Johns Hopkins Hospital (Baltimore)
-
Massachusetts
- Local Institution - 0124 (Boston)
-
Michigan
- Local Institution - 0119 (Ann Arbor)
-
Minnesota
- Local Institution - 0129 (Rochester)
- Local Institution - 0174 (Rochester)
- Local Institution - 0181 (Rochester)
-
New York
- Local Institution - 0142 (Buffalo)
- Local Institution - 0170 (New York)
- Memorial Sloan Kettering Cancer Center (New York)
-
North Carolina
- Local Institution - 0100 (Durham)
-
Norway
- Oslo Universitetssykehus HF, Ullevål (Oslo)
-
Ontario
- Local Institution - 0021 (Toronto)
- Local Institution - 0007 (Toronto)
-
Oost-Vlaanderen
- UZ Gent (Ghent)
-
Rhineland-Palatinate
- Local Institution - 0081 (Mainz)
-
Rhône
- Local Institution - 0075 (Pierre-Bénite)
-
Seoul-teukbyeolsi [Seoul]
- Seoul National University Hospital (Seoul)
- Severance Hospital, Yonsei University Health System (Seoul)
- Asan Medical Center (Seoul)
-
Shanghai Municipality
- Shanghai GoBroad Cancer Hospital China Pharmaceutical University (Shanghai)
- Fudan University Shanghai Cancer Center (Shanghai)
-
Spain
- Hospital Universitario Virgen Del Rocio (Seville)
-
Texas
- University of Texas MD Anderson Cancer Center (Houston)
-
Tokyo
- National Cancer Center Hospital (Chuo-ku)
-
Tuscany
- Local Institution - 0073 (Siena)
-
Val-de-Marne
- Local Institution - 0116 (Villejuif)
-
Washington
- Local Institution - 0086 (Seattle)
-
Wisconsin
- Local Institution - 0134 (Madison)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.